복강경 수술 기구 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2024-2032년)

The Global Laparoscopic Instruments Market was valued at USD 14.3 billion in 2023 and is projected to grow at a CAGR of 9.1% between 2024 and 2032. This growth is primarily driven by the rising number of laparoscopic procedures and the increasing preference for minimally invasive surgeries. The market's expansion is fueled by the growing need for these surgical techniques, which offer benefits like reduced recovery time and minimal scarring. With the increasing prevalence of obesity and related health issues, bariatric surgeries have seen significant growth. Furthermore, the rising occurrence of chronic conditions such as gastrointestinal disorders and cancers has heightened the need for laparoscopic surgeries, reinforcing the demand for innovative instruments in modern surgical practices.

Laparoscopic instruments are essential tools used in minimally invasive surgeries, where small incisions are made, and a camera is used to guide the surgeon. This technique allows for precise operations with minimal damage to surrounding tissues, enhancing patient outcomes. The market is segmented by product type, with laparoscopes leading in 2023 with a revenue of around USD 5.7 billion. Laparoscopes are vital in providing visual clarity during surgeries and are used across various specialties, including general surgery, gynecology, urology, and bariatrics, contributing to their dominance in the market.

By application, the general surgery segment held the majority share in 2023, generating USD 5.4 billion in revenue. This segment covers numerous procedures like appendectomies, hernia repairs, and gastrointestinal surgeries, driving significant demand for laparoscopic instruments due to their widespread use. The adoption of minimally invasive techniques in general surgery further boosts the demand for these tools. In terms of usage, disposable instruments led the market with a 52.6% revenue share in 2023. Disposable tools offer the advantage of reducing the risk of cross-contamination, ensuring compliance with strict sterility standards in healthcare settings.

By end-use, hospitals dominated the market, contributing USD 9.7 billion in revenue. Hospitals cater to a wide range of complex surgeries, demanding advanced equipment and handling a higher volume of patients, which fuels the need for laparoscopic instruments. Regionally, North America accounted for USD 6.5 billion in revenue in 2023, driven by a high incidence of chronic diseases and a preference for minimally invasive surgeries. The U.S. market is projected to grow significantly, supported by a robust healthcare infrastructure and favorable reimbursement policies.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Technological advancements in laparoscopic surgical instruments
    • 3.2.1.2 Growing preference for minimally invasive surgery
    • 3.2.1.3 Increasing number of laparoscopic procedures
    • 3.2.1.4 Strong product pipeline
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of the devices
    • 3.2.2.2 Stringent regulations
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Regulatory landscape
• 3.6 Future market trends
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Number of gynecological laparoscopic procedures by 10 major markets, 2021 - 2032
  • 3.9.1 U.S.
  • 3.9.2 Canada
  • 3.9.3 Germany
  • 3.9.4 UK
  • 3.9.5 France
  • 3.9.6 Spain
  • 3.9.7 Italy
  • 3.9.8 China
  • 3.9.9 Japan
  • 3.9.10 India
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Strategic positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Laparoscopes
  • 5.2.1 Video laparoscopes
  • 5.2.2 Fiber laparoscopes
• 5.3 Energy devices
• 5.4 Insufflators
• 5.5 Suction systems
• 5.6 Closure devices
• 5.7 Hand instruments
• 5.8 Access devices
• 5.9 Laparoscopic accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Procedures)

• 6.1 Key trends
• 6.2 Gynecological surgery
• 6.3 Urological surgery
• 6.4 Colorectal surgery
• 6.5 Bariatric surgery
• 6.6 General surgery
• 6.7 Pediatric surgery
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Usage, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Disposable
• 7.3 Reusable

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Aesculap, Inc. (B. Braun)
• 10.2 Apollo Endosurgery
• 10.3 Boston Scientific Corporation
• 10.4 CONMED Corporation
• 10.5 Cook Medical Inc.
• 10.6 Ethicon Inc. (Johnson & Johnson)
• 10.7 Intuitive Surgical
• 10.8 Karl Storz GmbH
• 10.9 Medtronic Plc (Covidien)
• 10.10 Microline Surgical
• 10.11 Olympus Corporation
• 10.12 Richard Wolf GmbH
• 10.13 Smith & Nephew Inc.
• 10.14 Stryker Corporation